CXCR4 and diffuse large B-cell lymphoma: We then finally moved forward to in vivo biodistribution studies in a Toledo cell line-derived subcutaneous CXCR4+ DLBCL mouse model to determine if the labeling of nanoparticles could significantly modify their original biodistribution pattern.